Auswahl der wissenschaftlichen Literatur zum Thema „Cyclin-dependent kinases“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Cyclin-dependent kinases" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Cyclin-dependent kinases":
Sclafani, Robert A. „Cyclin dependent kinase activating kinases“. Current Opinion in Cell Biology 8, Nr. 6 (Dezember 1996): 788–94. http://dx.doi.org/10.1016/s0955-0674(96)80079-2.
Malumbres, Marcos. „Cyclin-dependent kinases“. Genome Biology 15, Nr. 6 (2014): 122. http://dx.doi.org/10.1186/gb4184.
Harper, J. W., und P. D. Adams. „Cyclin-Dependent Kinases“. Chemical Reviews 101, Nr. 8 (August 2001): 2511–26. http://dx.doi.org/10.1021/cr0001030.
Gitig, Diana M., und Andrew Koff. „Cdk Pathway: Cyclin-Dependent Kinases and Cyclin-Dependent Kinase Inhibitors“. Molecular Biotechnology 19, Nr. 2 (2001): 179–88. http://dx.doi.org/10.1385/mb:19:2:179.
Dynlacht, B. D., K. Moberg, J. A. Lees, E. Harlow und L. Zhu. „Specific regulation of E2F family members by cyclin-dependent kinases.“ Molecular and Cellular Biology 17, Nr. 7 (Juli 1997): 3867–75. http://dx.doi.org/10.1128/mcb.17.7.3867.
Malumbres, Marcos, und Mariano Barbacid. „Mammalian cyclin-dependent kinases“. Trends in Biochemical Sciences 30, Nr. 11 (November 2005): 630–41. http://dx.doi.org/10.1016/j.tibs.2005.09.005.
Clarke, Paul R. „Cyclin-Dependent Kinases: CAK-handed kinase activation“. Current Biology 5, Nr. 1 (Januar 1995): 40–42. http://dx.doi.org/10.1016/s0960-9822(95)00013-3.
Canavese, Miriam, Loredana Santo und Noopur Raje. „Cyclin dependent kinases in cancer“. Cancer Biology & Therapy 13, Nr. 7 (Mai 2012): 451–57. http://dx.doi.org/10.4161/cbt.19589.
Park, David S., Fuhu Wang und Michael J. O’Hare. „Cyclin-dependent kinases and stroke“. Expert Opinion on Therapeutic Targets 5, Nr. 5 (Oktober 2001): 557–67. http://dx.doi.org/10.1517/14728222.5.5.557.
Harper, J. W., und P. D. Adams. „ChemInform Abstract: Cyclin-Dependent Kinases“. ChemInform 32, Nr. 41 (24.05.2010): no. http://dx.doi.org/10.1002/chin.200141284.
Dissertationen zum Thema "Cyclin-dependent kinases":
Kitsios, Georgios. „Characterization of Arabidopsis cyclin dependent kinases“. Thesis, University of East Anglia, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.426634.
Miller, Matthew P. Ph D. (Matthew Paul) Massachusetts Institute of Technology. „Meiotic regulation of cyclin-dependent kinases“. Thesis, Massachusetts Institute of Technology, 2013. http://hdl.handle.net/1721.1/79185.
Cataloged from PDF version of thesis.
Includes bibliographical references.
During meiosis, a single round of DNA replication is followed by two consecutive rounds of nuclear divisions called meiosis I and meiosis II. In meiosis I, homologous chromosomes segregate, while sister chromatids remain together. Determining how this unusual chromosome segregation behavior is established is central to understanding germ cell development. Here we show that preventing microtubule-kinetochore interactions during premeiotic S phase and prophase I is essential for establishing the meiosis I chromosome segregation pattern. Premature interactions of kinetochores with microtubules transform meiosis I into a mitosis-like division by disrupting two key meiosis I events: coorientation of sister kinetochores and protection of centromeric cohesin removal from chromosomes. Furthermore we find that restricting outer kinetochore assembly contributes to preventing premature engagement of microtubules with kinetochores. We propose that inhibition of microtubule-kinetochore interactions during premeiotic S phase and prophase I is central to establishing the unique meiosis I chromosome segregation pattern.
by Matthew P. Miller.
Ph.D.
Gomes, Felipe Campelo. „Analysis of cyclin dependent kinases in Leishmania“. Thesis, University of Glasgow, 2007. http://theses.gla.ac.uk/32/.
Secombe, Julie. „Identification of novel G1 to S phase regulators in Drosophila /“. Title page, contents and abstract only, 1999. http://web4.library.adelaide.edu.au/theses/09PH/09phs4448.pdf.
Crack, Donna. „Analysis of the function of Drosophila cyclin E isoforms and identification of interactors“. Title page, table of contents and abstract only, 2002. http://web4.library.adelaide.edu.au/theses/09PH/09phc8837.pdf.
Dixon-Clarke, Sarah. „Structure and inhibition of novel cyclin-dependent kinases“. Thesis, University of Oxford, 2015. https://ora.ox.ac.uk/objects/uuid:3c6955c9-469a-4f4b-9577-309ccb57b742.
Sallam, Hatem. „Pharmacological and analytical studies of the cyclin dependent kinase inhibitors“. Stockholm, 2009. http://diss.kib.ki.se/2009/978-91-7409-706-1/.
Alexiou, Konstantinos G. „Cyclin-dependent kinases and nuclear functions in Arabidopsis thaliana“. Thesis, University of East Anglia, 2011. https://ueaeprints.uea.ac.uk/34236/.
Henderson, Andrew. „Isosteres of sulfonamide inhibitors of cyclin-dependent kinases (CDKs)“. Thesis, University of Newcastle Upon Tyne, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.512187.
Cheng, Kai. „Identification of Pctaire1 as a p35-interacting protein and a novel substrate for Cdk5 /“. View Abstract or Full-Text, 2003. http://library.ust.hk/cgi/db/thesis.pl?BICH%202003%20CHENG.
Includes bibliographical references (leaves 153-177). Also available in electronic version. Access restricted to campus users.
Bücher zum Thema "Cyclin-dependent kinases":
Dyson, Nicholas, Johannes Walter und Orna Cohen-Fix. Abstracts of papers presented at the 2008 meeting on the cell cycle: May 14-May 18, 2008. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory, 2008.
Musunuru, Kiran. Cell cycle regulators in cancer. Basel: Karger Landes Systems, 1997.
D, Inzé, Hrsg. The cell cycle control and plant development. Oxford, UK: Blackwell Pub., 2007.
B, Kastan M., und Imperial Cancer Research Fund (Great Britain), Hrsg. Checkpoint controls and cancer. Plainview, NY: Cold Spring Harbor Laboratory Press, 1997.
Vogt, Peter K., und Steven I. Reed, Hrsg. Cyclin Dependent Kinase (CDK) Inhibitors. Berlin, Heidelberg: Springer Berlin Heidelberg, 1998. http://dx.doi.org/10.1007/978-3-642-71941-7.
Orzáez, Mar, Mónica Sancho Medina und Enrique Pérez-Payá, Hrsg. Cyclin-Dependent Kinase (CDK) Inhibitors. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-2926-9.
Ip, Nancy Y., und Li-Huei Tsai, Hrsg. Cyclin Dependent Kinase 5 (Cdk5). Boston, MA: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-78887-6.
Chen, Ginny. Analysis of Saccharomyces cerevisiae cyclin dependent kinase inhibitor Far1. Ottawa: National Library of Canada, 2003.
Su, Yi. Phosphorylation and Regulation of the Wnt co-Receptor LRP6 by Cyclin Dependent Kinase 14/Cyclin Y and Tyrosine Kinase Fer. [S.l: s.n.], 2014.
Logan, Angela Berti. Characterization of new alleles of PHO85, a cyclin-dependent kinase of Saccharomyces cerevisiae. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1999.
Buchteile zum Thema "Cyclin-dependent kinases":
Golsteyn, Roy M. „Cyclin-Dependent Kinases“. In Encyclopedia of Cancer, 1–4. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-27841-9_1429-2.
Golsteyn, Roy M. „Cyclin-Dependent Kinases“. In Encyclopedia of Cancer, 1269–73. Berlin, Heidelberg: Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-662-46875-3_1429.
Malumbres, Marcos. „Cyclins and Cyclin-dependent Kinases“. In Encyclopedia of Systems Biology, 509–12. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-9863-7_10.
Meijer, Laurent. „Chemical inhibitors of cyclin-dependent kinases“. In Progress in Cell Cycle Research, 351–63. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-1809-9_29.
Law, Mary E., und Brian K. Law. „Cyclin-Dependent Kinases as Therapeutic Targets“. In Encyclopedia of Molecular Pharmacology, 505–7. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-57401-7_10043.
Law, Mary E., und Brian K. Law. „Cyclin-dependent kinases as therapeutic targets“. In Encyclopedia of Molecular Pharmacology, 1–3. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-21573-6_10043-1.
Koff, Andrew, und Kornelia Polyak. „p27KIP1, an inhibitor of cyclin-dependent kinases“. In Progress in Cell Cycle Research, 141–47. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-1809-9_11.
Li, Yan, Christopher W. Jenkins, Michael A. Nichols, Xiaoyu Wu, Kun-Liang Guan und Yue Xiong. „p16 Family Inhibitors of Cyclin-Dependent Kinases“. In Cancer Genes, 57–82. Boston, MA: Springer US, 1996. http://dx.doi.org/10.1007/978-1-4615-5895-8_4.
Johnson, Neil, und Geoffrey I. Shapiro. „Targeting Cyclin-Dependent Kinases for Cancer Therapy“. In Cell Cycle Deregulation in Cancer, 167–85. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-1770-6_11.
Boutros, Rose. „Regulation of Centrosomes by Cyclin-Dependent Kinases“. In The Centrosome, 187–97. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-62703-035-9_11.
Konferenzberichte zum Thema "Cyclin-dependent kinases":
Surin, Svyatoslav Sergeevich, und G. L. Snigur. „Expression of cyclin-dependent kinases in pancreatic islets during experimental hyperglycemia“. In International Research Conference on Technology, Science, Engineering & Management. Seattle: Профессиональная наука, 2021. http://dx.doi.org/10.54092/9781365973192_35.
Surin, Svyatoslav Sergeevich, und G. L. Snigur. „Expression of cyclin-dependent kinases in pancreatic islets during experimental hyperglycemia“. In International Research Conference on Technology, Science, Engineering & Management. Seattle: Профессиональная наука, 2021. http://dx.doi.org/10.54092/9781365973192_35.
Денисова, Дарья Андреевна. „CYCLIN-DEPENDENT KINASES CDK8 / 19 AND THEIR INFLUENCE ON THE ORIGIN AND DEVELOPMENT OF TUMOR PROCESSES“. In Наука. Исследования. Практика: сборник избранных статей по материалам Международной научной конференции (Санкт-Петербург, Апрель 2020). Crossref, 2020. http://dx.doi.org/10.37539/srp290.2020.80.21.015.
Kholmurodov, Kholmirzo T., Yu E. Penionzhkevich und E. A. Cherepanov. „Computer Molecular Dynamics Studies on Protein Structures (Visual Pigment Rhodopsin and Cyclin-Dependent Kinases)“. In INTERNATIONAL SYMPOSIUM ON EXOTIC NUCLEI. AIP, 2007. http://dx.doi.org/10.1063/1.2746628.
Kunadharaju, R., A. Saradna, M. Ahmad und G. Fuhrer. „Palbociclib (Cyclin-Dependent Kinases CDK4 and CDK6 Selective Inhibitor) Induced Grade 3 Interstitial Pneumonitis“. In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2118.
Sankaranarayanan, Ranjini, Rakesh Dachineni, Siddharth Kesharwani, Ramesh Kumar Dhandapani, Hemachand Tummala und Jayarama B. Gunaje. „Abstract 4411: Identification of novel natural compounds as potential inhibitors of cyclin dependent kinases“. In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-4411.
Sankaranarayanan, Ranjini, Rakesh Dachineni, Siddharth Kesharwani, Ramesh Kumar Dhandapani, Hemachand Tummala und Jayarama B. Gunaje. „Abstract 4411: Identification of novel natural compounds as potential inhibitors of cyclin dependent kinases“. In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-4411.
Fu, Wei, Le Ma, Baoky Chu, Xue Wang, Tapan K. Bagui, Marilyn M. Bui, Jennifer Gemmer, Soner Altiok, Douglas G. Letson und W. Jack Pledger. „Abstract 3596: SCH727965, a cyclin-dependent kinases inhibitor, induces apoptosis in sarcoma cells through caspase 3- dependent pathway“. In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3596.
Ramos Rodríguez, J., S. Hernández Rojas, I. González Perera, MM Viña Romero, GJ Nazco Casariego, FJ Merino Alonso, S. García Gil, B. Del Rosario García, L. Cantarelli und F. Gutiérrez Nicolás. „5PSQ-059 Cyclin dependent kinases 4/6 inhibitors: new options in hr+ her2- breast cancer“. In 24th EAHP Congress, 27th–29th March 2019, Barcelona, Spain. British Medical Journal Publishing Group, 2019. http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.492.
Tien, Amy H., Nasrin R. Mawji, Jun Wang und Marianne D. Sadar. „Abstract 1000: Targeting androgen receptors and cyclin-dependent kinases 4 and 6 in breast cancer“. In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-1000.
Berichte der Organisationen zum Thema "Cyclin-dependent kinases":
Wohlschlegel, James, und Anindya Dutta. Development of Inhibitors That Selectively Disrupt Substrate Recognition by Cyclin-Dependent Kinases. Fort Belvoir, VA: Defense Technical Information Center, August 2002. http://dx.doi.org/10.21236/ada410428.
Donovan, Joseph. Development and Use of Novel Tools to Directly Screen for Substrates of Cyclin Dependent Kinases. Fort Belvoir, VA: Defense Technical Information Center, August 1999. http://dx.doi.org/10.21236/ada376126.
Donovan, Joseph. Development and Use of Novel Tools to Directly Screen for Substrates of Cyclin Dependent Kinases. Fort Belvoir, VA: Defense Technical Information Center, August 2000. http://dx.doi.org/10.21236/ada392561.
Williams, Stephen D. Cyclin Dependent Kinase Inhibitors as Targets in Ovarian Cancer. Fort Belvoir, VA: Defense Technical Information Center, Oktober 2005. http://dx.doi.org/10.21236/ada446399.
Williams, Stephen D. Cyclin Dependent Kinase Inhibitors as Targets in Ovarian Cancer. Fort Belvoir, VA: Defense Technical Information Center, Oktober 2002. http://dx.doi.org/10.21236/ada411751.
Williams, Stephen D. Cyclin Dependent Kinase Inhibitors as Targets in Ovarian Cancer. Fort Belvoir, VA: Defense Technical Information Center, Oktober 2003. http://dx.doi.org/10.21236/ada420941.
Harper, J. W. The Role of Cyclin Dependent Kinase Inhibitor, Cip1, in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, Oktober 1998. http://dx.doi.org/10.21236/ada366917.
Harper, J. W. The Role of Cyclin Dependent Kinase Inhibitor, CIP1, in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, Oktober 1995. http://dx.doi.org/10.21236/ada302399.
Harper, J. W. The Role of Cyclin Dependent Kinase Inhibitor, CIP1, in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, Oktober 1997. http://dx.doi.org/10.21236/ada341520.
Harper, J. W. The Role of Cyclin Dependent Kinase Inhibitor, CIP1, in Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, Oktober 1999. http://dx.doi.org/10.21236/ada381538.